Alto Neuroscience, Financials
| ANRO Stock | 2.65 0.04 1.49% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.26 | 16.9202 |
|
|
Investors should never underestimate Alto Neuroscience,'s ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Alto Neuroscience,'s cash flow, debt, and profitability to make informed and accurate decisions about investing in Alto Neuroscience,.
Net Income |
|
Alto | Select Account or Indicator |
Understanding current and past Alto Neuroscience, Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Alto Neuroscience,'s financial statements are interrelated, with each one affecting the others. For example, an increase in Alto Neuroscience,'s assets may result in an increase in income on the income statement.
Alto Neuroscience, Stock Summary
Alto Neuroscience, competes with Ultra Clean, Zedge, NETGEAR, Anterix, and Globalstar, Common. Alto Neuroscience, is entity of United States. It is traded as Stock on NYSE exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | New York Stock Exchange |
| CUSIP | 02157Q109 |
| Location | California; U.S.A |
| Business Address | 369 South San |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.altoneuroscience.com |
| Phone | 650 200 0412 |
Alto Neuroscience, Key Financial Ratios
| Return On Equity | -0.57 | ||||
| EBITDA | (68.61 M) | ||||
| Net Income | (61.43 M) | ||||
| Book Value Per Share | 6.12 X | ||||
| Market Capitalization | 72.55 M |
Alto Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Alto Neuroscience,'s current stock value. Our valuation model uses many indicators to compare Alto Neuroscience, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alto Neuroscience, competition to find correlations between indicators driving Alto Neuroscience,'s intrinsic value. More Info.Alto Neuroscience, is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . At this time, Alto Neuroscience,'s Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alto Neuroscience,'s earnings, one of the primary drivers of an investment's value.Alto Neuroscience, Systematic Risk
Alto Neuroscience,'s systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Alto Neuroscience, volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on Alto Neuroscience, correlated with the market. If Beta is less than 0 Alto Neuroscience, generally moves in the opposite direction as compared to the market. If Alto Neuroscience, Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Alto Neuroscience, is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Alto Neuroscience, is generally in the same direction as the market. If Beta > 1 Alto Neuroscience, moves generally in the same direction as, but more than the movement of the benchmark.
Alto Neuroscience, Thematic Clasifications
Alto Neuroscience, is part of several thematic ideas from Health Management to IT. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasToday, most investors in Alto Neuroscience, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Alto Neuroscience,'s growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Alto Neuroscience, growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Alto Neuroscience, March 22, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Alto Neuroscience, help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Alto Neuroscience,. We use our internally-developed statistical techniques to arrive at the intrinsic value of Alto Neuroscience, based on widely used predictive technical indicators. In general, we focus on analyzing Alto Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Alto Neuroscience,'s daily price indicators and compare them against related drivers.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 26.99 | |||
| Value At Risk | (8.14) | |||
| Potential Upside | 8.07 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alto Neuroscience,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Alto Stock, please use our How to Invest in Alto Neuroscience, guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alto Neuroscience,. If investors know Alto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alto Neuroscience, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Alto Neuroscience, is measured differently than its book value, which is the value of Alto that is recorded on the company's balance sheet. Investors also form their own opinion of Alto Neuroscience,'s value that differs from its market value or its book value, called intrinsic value, which is Alto Neuroscience,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alto Neuroscience,'s market value can be influenced by many factors that don't directly affect Alto Neuroscience,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alto Neuroscience,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Alto Neuroscience, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alto Neuroscience,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.